| Authors: |
Burman RJ; Department of Pharmacology, University of Oxford, Oxford, UK. richard.burman@ndcn.ox.ac.uk.; Oxford Epilepsy Research Group, NIHR Biomedical Research Centre, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. richard.burman@ndcn.ox.ac.uk.; Department of Neuropediatrics, University Children's Hospital Zürich, Zürich, Switzerland. richard.burman@ndcn.ox.ac.uk., Rosch RE; Department of Neuropediatrics, University Children's Hospital Zürich, Zürich, Switzerland.; MRC Centre for Neurodevelopmental Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Wilmshurst JM; Department of Paediatric Neurology, Red Cross War Memorial Children's Hospital, Cape Town, South Africa.; Neuroscience Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Sen A; Oxford Epilepsy Research Group, NIHR Biomedical Research Centre, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK., Ramantani G; Department of Neuropediatrics, University Children's Hospital Zürich, Zürich, Switzerland., Akerman CJ; Department of Pharmacology, University of Oxford, Oxford, UK., Raimondo JV; Neuroscience Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. joseph.raimondo@uct.ac.za.; Division of Cell Biology, Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. joseph.raimondo@uct.ac.za.; Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. joseph.raimondo@uct.ac.za. |
